Webb14 nov. 2024 · Singh JA, Hossain A, Mudano AS, et al. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta … Webb1 juli 2014 · The goal of this study was to review and summarize the efficacy and safety of use of tofacitinib for treating rheumatoid arthritis (RA). Methods A systematic literature …
A Review of Tofacitinib in the Treatment of Rheumatoid Arthritis …
WebbAnti–tumor necrosis factor agents (anti-TNFs) have changed the course of rheumatoid arthritis (RA) for more than a decade. ... A systematic literature review was conducted to identify English-language articles indexed in PubMed from July 1999 through June 2013 reporting results regarding anti-TNF discontinuation in patients with RA. Webb1 dec. 2014 · The mechanism of action, pharmacodynamics, pharmacokinetics, and metabolism of tofacitinib, a novel Janus kinase (JAK) inhibitor, are reviewed and the … molly duggan associates
Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy
Webb1 jan. 2024 · Tofacitinib is a Janus kinase inhibitor indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who demonstrate inadequate … Webb22 mars 2024 · Strand, V. et al. Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in … WebbCorrespondence: Bincy P Abraham, Houston Methodist Gastroenterology Associates, 6550 Fannin St, Suite 1201, Houston, TX, 77030, USA, Tel +1 713-441-8374, Email [email protected]. Abstract: This review addresses appropriate patient selection for upadacitinib, a Janus kinase inhibitor approved by the FDA and EMA for … molly dugan vermont